What is Intrapharm Laboratories?
Intrapharm Laboratories, headquartered in the United Kingdom, is a pharmaceutical company with extensive experience in commercializing pharmaceutical products. The management team leverages deep expertise to foster forward-thinking partnerships, serving both international and UK markets with a flexible and reliable service. The company's consistent year-on-year growth in its product portfolio highlights a dedicated commitment to investing in niche and branded pharmaceuticals. Intrapharm is part of the Riemser Group of Companies, demonstrating its integration within a larger corporate structure and its capacity to manage products from registration through to patient delivery.
How much funding has Intrapharm Laboratories raised?
Intrapharm Laboratories has raised a total of $3.3M across 1 funding round:
Private Equity
$3.3M
Private Equity (2014): $3.3M with participation from Business Growth Fund
Key Investors in Intrapharm Laboratories
Business Growth Fund
Business Growth Fund (BGF) is a prominent UK-based investor focused on supporting small and mid-sized businesses. They provide capital to companies across various stages of growth, demonstrating a commitment to fostering economic expansion.
What's next for Intrapharm Laboratories?
The substantial enterprise-level funding and recent strategic investment indicate that Intrapharm Laboratories is likely in a scaling or expansion phase. This capital infusion is expected to fuel further development of its product portfolio, potentially through acquisitions or enhanced R&D initiatives. The company's focus on forming successful partnerships suggests a strategy geared towards market penetration and broadening its service offerings. Future growth may involve expanding its reach into new therapeutic areas or geographical markets, solidifying its position as a key player in the pharmaceutical sector.
See full Intrapharm Laboratories company page
